Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
21348 | 422 | 34.3 | 84% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
127 | 3 | OXYTOCIN//BEHAVIORAL SCIENCES//VASOPRESSIN | 67291 |
276 | 2 | OXYTOCIN//VASOPRESSIN//HYPONATREMIA | 19172 |
21348 | 1 | COPEPTIN//BRAHMS AKTIENGESELL//RULE OUT | 422 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | COPEPTIN | authKW | 9469813 | 41% | 75% | 175 |
2 | BRAHMS AKTIENGESELL | address | 289431 | 1% | 100% | 4 |
3 | RULE OUT | authKW | 236361 | 2% | 47% | 7 |
4 | EXPT CLIN ENDOCRINOL MED CLIN 1 | address | 162803 | 1% | 75% | 3 |
5 | 1 YEAR OUTCOME | authKW | 128632 | 1% | 44% | 4 |
6 | GRP EMERGENCIES PROC PATHOL | address | 96476 | 0% | 67% | 2 |
7 | THERMO SCI BIOMARKERS | address | 81399 | 1% | 38% | 3 |
8 | 1 1 4 3 ACETYLAMINOPROPOXY BENZOYL 4 PIPERIDYL 3 4 DIHYDRO 21H QUINOLINONE | authKW | 72358 | 0% | 100% | 1 |
9 | ADIPOSE FUNCTION | authKW | 72358 | 0% | 100% | 1 |
10 | ARGININE VASOPRESSIN COPEPTIN PLASMA CONCENTRATIONS SEPSIS SEPTIC SHOCK | authKW | 72358 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Endocrinology & Metabolism | 1544 | 24% | 0% | 101 |
2 | Medical Laboratory Technology | 731 | 7% | 0% | 30 |
3 | Cardiac & Cardiovascular System | 550 | 15% | 0% | 64 |
4 | Urology & Nephrology | 410 | 10% | 0% | 41 |
5 | Emergency Medicine | 394 | 4% | 0% | 18 |
6 | Peripheral Vascular Diseases | 202 | 7% | 0% | 30 |
7 | Critical Care Medicine | 193 | 5% | 0% | 19 |
8 | Medicine, Research & Experimental | 109 | 7% | 0% | 30 |
9 | Medicine, General & Internal | 53 | 7% | 0% | 29 |
10 | Nutrition & Dietetics | 23 | 3% | 0% | 11 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BRAHMS AKTIENGESELL | 289431 | 1% | 100% | 4 |
2 | EXPT CLIN ENDOCRINOL MED CLIN 1 | 162803 | 1% | 75% | 3 |
3 | GRP EMERGENCIES PROC PATHOL | 96476 | 0% | 67% | 2 |
4 | THERMO SCI BIOMARKERS | 81399 | 1% | 38% | 3 |
5 | BIOCHIMY | 72358 | 0% | 100% | 1 |
6 | BONIFRATROW KATOWICACH | 72358 | 0% | 100% | 1 |
7 | COCHRANE RENAL GRPCHILDRENS HOSP WESTMEAD | 72358 | 0% | 100% | 1 |
8 | DEPORTMENT ACCID EMERGENCY MED | 72358 | 0% | 100% | 1 |
9 | DIABET ZENTRUM CAMPUS INNENSTADT | 72358 | 0% | 100% | 1 |
10 | E2CRC | 72358 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PEPTIDES | 1601 | 3% | 0% | 14 |
2 | BIOMARKERS IN MEDICINE | 936 | 1% | 0% | 3 |
3 | JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 860 | 4% | 0% | 17 |
4 | ANNALS OF NUTRITION AND METABOLISM | 846 | 1% | 0% | 5 |
5 | INTERNATIONAL JOURNAL OF CARDIOLOGY | 724 | 3% | 0% | 11 |
6 | DIABETES & VASCULAR DISEASE RESEARCH | 714 | 0% | 0% | 2 |
7 | NATURE REVIEWS NEPHROLOGY | 641 | 0% | 0% | 2 |
8 | CLINICAL CHEMISTRY AND LABORATORY MEDICINE | 612 | 1% | 0% | 6 |
9 | EUROPEAN GERIATRIC MEDICINE | 599 | 0% | 0% | 2 |
10 | CLINICAL CHEMISTRY | 599 | 2% | 0% | 10 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | LUKASZYK, E , MALYSZKO, J , (2015) COPEPTIN: PATHOPHYSIOLOGY AND POTENTIAL CLINICAL IMPACT.ADVANCES IN MEDICAL SCIENCES. VOL. 60. ISSUE 2. P. 335 -341 | 55 | 77% | 4 |
2 | REINSTADLER, SJ , KLUG, G , FEISTRITZER, HJ , METZLER, B , MAIR, J , (2015) COPEPTIN TESTING IN ACUTE MYOCARDIAL INFARCTION: READY FOR ROUTINE USE?.DISEASE MARKERS. VOL. . ISSUE . P. 1 -9 | 63 | 62% | 2 |
3 | YALTA, K , YALTA, T , SIVRI, N , YETKIN, E , (2013) COPEPTIN AND CARDIOVASCULAR DISEASE: A REVIEW OF A NOVEL NEUROHORMONE.INTERNATIONAL JOURNAL OF CARDIOLOGY. VOL. 167. ISSUE 5. P. 1750-1759 | 51 | 66% | 27 |
4 | LEWANDOWSKI, KC , BRABANT, G , (2016) POTENTIAL CLINICAL UTILITY OF COPEPTIN (C-TERMINAL PROVASOPRESSIN) MEASUREMENTS IN CLINICAL MEDICINE.EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES. VOL. 124. ISSUE 3. P. 173 -177 | 47 | 72% | 1 |
5 | DOBSA, L , EDOZIEN, KC , (2013) COPEPTIN AND ITS POTENTIAL ROLE IN DIAGNOSIS AND PROGNOSIS OF VARIOUS DISEASES.BIOCHEMIA MEDICA. VOL. 23. ISSUE 2. P. 172 -190 | 41 | 84% | 19 |
6 | SUN, H , SUN, T , MA, B , YANG, BW , ZHANG, Y , HUANG, DH , SHI, JP , (2015) PREDICTION OF ALL-CAUSE MORTALITY WITH COPEPTIN IN CARDIO-CEREBROVASCULAR PATIENTS: A META-ANALYSIS OF PROSPECTIVE STUDIES.PEPTIDES. VOL. 69. ISSUE . P. 9 -18 | 34 | 74% | 4 |
7 | MORAWIEC, B , KAWECKI, D , (2013) COPEPTIN: A NEW MARKER IN CARDIOLOGY.JOURNAL OF CARDIOVASCULAR MEDICINE. VOL. 14. ISSUE 1. P. 19 -25 | 43 | 61% | 9 |
8 | BALLING, L , GUSTAFSSON, F , (2016) COPEPTIN IN HEART FAILURE.ADVANCES IN CLINICAL CHEMISTRY, VOL 73. VOL. 73. ISSUE . P. 29 -64 | 51 | 49% | 0 |
9 | LIPINSKI, MJ , ESCARCEGA, RO , D'ASCENZO, F , MAGALHAES, MA , BAKER, NC , TORGUSON, R , CHEN, F , EPSTEIN, SE , MIRO, O , LLORENS, P , ET AL (2014) A SYSTEMATIC REVIEW AND COLLABORATIVE META-ANALYSIS TO DETERMINE THE INCREMENTAL VALUE OF COPEPTIN FOR RAPID RULE-OUT OF ACUTE MYOCARDIAL INFARCTION.AMERICAN JOURNAL OF CARDIOLOGY. VOL. 113. ISSUE 9. P. 1581 -1591 | 30 | 67% | 27 |
10 | YILMAN, M , ERENLER, AK , BAYDIN, A , (2015) COPEPTIN: A DIAGNOSTIC FACTOR FOR CRITICAL PATIENTS.EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES. VOL. 19. ISSUE 16. P. 3030 -3036 | 29 | 83% | 0 |
Classes with closest relation at Level 1 |